Page last updated: 2024-10-16

quinacrine and Asthenia

quinacrine has been researched along with Asthenia in 2 studies

Quinacrine: An acridine derivative formerly widely used as an antimalarial but superseded by chloroquine in recent years. It has also been used as an anthelmintic and in the treatment of giardiasis and malignant effusions. It is used in cell biological experiments as an inhibitor of phospholipase A2.
quinacrine : A member of the class of acridines that is acridine substituted by a chloro group at position 6, a methoxy group at position 2 and a [5-(diethylamino)pentan-2-yl]nitrilo group at position 9.

Asthenia: Clinical sign or symptom manifested as debility, or lack or loss of strength and energy.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
SCHAMBERG, IL1
Huriez, C1
Desmons, F1
Gautier, G1

Other Studies

2 other studies available for quinacrine and Asthenia

ArticleYear
Studies on post-atabrine dermatitis. II. Permanent anhidrosis, anhidrotic asthenia and prolonged dermatitis following atabrine dermatitis.
    The Journal of investigative dermatology, 1953, Volume: 21, Issue:5

    Topics: Asthenia; Dermatitis; Drug Eruptions; Humans; Hypohidrosis; Quinacrine; Sweating

1953
[Complications with synthetic antimalarials].
    Lille medical : journal de la Faculte de medecine et de pharmacie de l'Universite de Lille, 1969, Volume: 14, Issue:8

    Topics: Antimalarials; Asthenia; Central Nervous System Diseases; Chloroquine; Drug Eruptions; Eczema; Eye D

1969